137 related articles for article (PubMed ID: 8075050)
1. Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study.
Abrahamsen AF; Lien HH; Aas M; Winderen M; Hager B; Kvaløy S; Elgjo RF; Nome O
Ann Oncol; 1994 May; 5(5):433-6. PubMed ID: 8075050
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study.
Bendini M; Zuiani C; Bazzocchi M; Dalpiaz G; Zaja F; Englaro E
MAGMA; 1996; 4(3-4):213-24. PubMed ID: 9220410
[TBL] [Abstract][Full Text] [Related]
3. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
[TBL] [Abstract][Full Text] [Related]
4. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma.
Gasparini MD; Balzarini L; Castellani MR; Tesoro Tess JD; Maffioli LS; Petrillo R; Ceglia E; Musumeci R; Buraggi GL
Cancer; 1993 Jul; 72(2):577-82. PubMed ID: 8319190
[TBL] [Abstract][Full Text] [Related]
5. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
6. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
[TBL] [Abstract][Full Text] [Related]
7. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
[No Abstract] [Full Text] [Related]
8. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
[TBL] [Abstract][Full Text] [Related]
9. Value of imaging for the diagnosis of residual mediastinal mass in malignant lymphomas.
Brice P; Rain JD; Frija J
Nouv Rev Fr Hematol (1978); 1991; 33(6):531-2. PubMed ID: 1818310
[TBL] [Abstract][Full Text] [Related]
10. Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?
Maisey NR; Hill ME; Webb A; Cunningham D; Flux GD; Padhani A; Ott RJ; Norman A; Bishop L
Eur J Cancer; 2000 Jan; 36(2):200-6. PubMed ID: 10741278
[TBL] [Abstract][Full Text] [Related]
11. Gallium citrate Ga 67 scanning: clinical usefulness in lymphoma patients.
Seabold JE; Votaw ML; Keyes JW; Foley WD; Balachandran S; Gill SP
Arch Intern Med; 1976 Dec; 136(12):1370-4. PubMed ID: 793551
[TBL] [Abstract][Full Text] [Related]
12. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
[TBL] [Abstract][Full Text] [Related]
13. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
[TBL] [Abstract][Full Text] [Related]
14. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
[TBL] [Abstract][Full Text] [Related]
15. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
16. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
18. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
Hill M; Cunningham D; MacVicar D; Roldan A; Husband J; McCready R; Mansi J; Milan S; Hickish T
J Clin Oncol; 1993 Nov; 11(11):2273-8. PubMed ID: 8229142
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
Mody RJ; Bui C; Hutchinson RJ; Frey KA; Shulkin BL
Leuk Lymphoma; 2007 Apr; 48(4):699-707. PubMed ID: 17454627
[TBL] [Abstract][Full Text] [Related]
20. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
